Ignota Labs DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patents & Exclusivities, Dossier, Manufacturer, Licensing, Distributer, Suppliers, News

Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

Virtual Booth

Contact Supplier

Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

VISIT THE VIRTUAL BOOTH
Review portfolio & marketing content
CONTACT DETAILS
Google Map, LinkedIn, Emails...

DIGITAL CONTENT

2 News #PharmaBuzz

media
2 News #PharmaBuzz

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Ignota Labs employs a novel strategy to build a pipeline of high-value therapies. The company identifies promising drug candidates that have been abandoned due to safety concerns - typically 80-90% of the way to success - and uses SAFEPATH to determine the underlying issues and develop solutions. This model not only reduces development timelines by years and costs by millions, but also offers multi-billion-dollar potential for each recovered therapy. In just two years, Ignota Labs has demonstrated the power of its approach. The company successfully in-licensed its first asset, a first-in-class metabolic health drug with the potential to impr